Biotage AB (publ) (BIOT.ST)
SEK 141.1
(0.21%)
SEK 141.1
(0.21%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 150 Million SEK | 19.35% |
| 2022 | 217 Million SEK | 6.9% |
| 2021 | 203 Million SEK | -4.56% |
| 2020 | 212.69 Million SEK | -10.51% |
| 2019 | 237.66 Million SEK | 114.88% |
| 2018 | 110.6 Million SEK | 16759.91% |
| 2017 | 656 Thousand SEK | -19.51% |
| 2016 | 815 Thousand SEK | -24.19% |
| 2015 | 1.07 Million SEK | -89.37% |
| 2014 | 10.11 Million SEK | -59.44% |
| 2013 | 24.93 Million SEK | -11.59% |
| 2012 | 28.2 Million SEK | 348.19% |
| 2011 | 6.29 Million SEK | -7.97% |
| 2010 | 6.83 Million SEK | 647.21% |
| 2009 | 915 Thousand SEK | -98.05% |
| 2008 | 46.89 Million SEK | -34.77% |
| 2007 | 71.89 Million SEK | -12.0% |
| 2006 | 81.69 Million SEK | 47.38% |
| 2005 | 55.42 Million SEK | 2.31% |
| 2004 | 54.17 Million SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 440 Million SEK | -33.03% |
| 2024 Q1 | 657 Million SEK | 4.78% |
| 2024 Q3 | 150 Million SEK | -43.18% |
| 2023 Q3 | 408 Million SEK | 9.09% |
| 2023 FY | 627 Million SEK | 188.94% |
| 2023 Q4 | 627 Million SEK | 53.68% |
| 2023 Q2 | 374 Million SEK | 70.78% |
| 2023 Q1 | 219 Million SEK | 0.92% |
| 2022 Q3 | 250 Million SEK | 2.88% |
| 2022 Q4 | 217 Million SEK | -13.2% |
| 2022 Q1 | 244 Million SEK | 20.2% |
| 2022 FY | 217 Million SEK | 6.9% |
| 2022 Q2 | 243 Million SEK | -0.41% |
| 2021 Q3 | 108 Million SEK | -1.87% |
| 2021 FY | 203 Million SEK | -4.56% |
| 2021 Q1 | 230.63 Million SEK | 8.44% |
| 2021 Q2 | 110.06 Million SEK | -52.28% |
| 2021 Q4 | 203 Million SEK | 87.96% |
| 2020 Q3 | 224.24 Million SEK | -1.13% |
| 2020 Q2 | 226.82 Million SEK | -11.85% |
| 2020 FY | 212.69 Million SEK | -10.51% |
| 2020 Q1 | 257.3 Million SEK | 8.27% |
| 2020 Q4 | 212.69 Million SEK | -5.15% |
| 2019 Q2 | 282.11 Million SEK | 15.69% |
| 2019 FY | 237.66 Million SEK | 114.88% |
| 2019 Q4 | 237.66 Million SEK | -1.26% |
| 2019 Q1 | 243.84 Million SEK | 120.48% |
| 2019 Q3 | 240.69 Million SEK | -14.68% |
| 2018 Q1 | 109.94 Million SEK | 16659.3% |
| 2018 Q4 | 110.6 Million SEK | 0.61% |
| 2018 FY | 110.6 Million SEK | 16759.91% |
| 2018 Q3 | 109.92 Million SEK | -0.01% |
| 2018 Q2 | 109.93 Million SEK | -0.0% |
| 2017 Q1 | 773 Thousand SEK | -5.15% |
| 2017 Q4 | 656 Thousand SEK | -3.39% |
| 2017 Q3 | 679 Thousand SEK | -6.6% |
| 2017 FY | 656 Thousand SEK | -19.51% |
| 2017 Q2 | 727 Thousand SEK | -5.95% |
| 2016 Q4 | 815 Thousand SEK | -5.89% |
| 2016 Q2 | 910 Thousand SEK | -6.57% |
| 2016 Q1 | 974 Thousand SEK | -9.4% |
| 2016 FY | 815 Thousand SEK | -24.19% |
| 2016 Q3 | 866 Thousand SEK | -4.84% |
| 2015 Q4 | 1.07 Million SEK | -82.9% |
| 2015 FY | 1.07 Million SEK | -89.37% |
| 2015 Q1 | 10.21 Million SEK | 0.98% |
| 2015 Q3 | 6.28 Million SEK | 1.16% |
| 2015 Q2 | 6.21 Million SEK | -39.13% |
| 2014 Q1 | 26.1 Million SEK | 4.72% |
| 2014 Q2 | 19.84 Million SEK | -23.98% |
| 2014 Q4 | 10.11 Million SEK | -48.59% |
| 2014 FY | 10.11 Million SEK | -59.44% |
| 2014 Q3 | 19.66 Million SEK | -0.91% |
| 2013 Q2 | 5.89 Million SEK | 15.93% |
| 2013 Q3 | 5.68 Million SEK | -3.58% |
| 2013 FY | 24.93 Million SEK | -11.59% |
| 2013 Q4 | 24.93 Million SEK | 338.62% |
| 2013 Q1 | 5.08 Million SEK | -81.97% |
| 2012 Q4 | 28.2 Million SEK | 388.06% |
| 2012 Q1 | 6.09 Million SEK | -3.18% |
| 2012 Q2 | 6.09 Million SEK | 0.1% |
| 2012 FY | 28.2 Million SEK | 348.19% |
| 2012 Q3 | 5.77 Million SEK | -5.25% |
| 2011 Q2 | 6.28 Million SEK | -2.59% |
| 2011 FY | 6.29 Million SEK | -7.97% |
| 2011 Q3 | 6.44 Million SEK | 2.61% |
| 2011 Q4 | 6.29 Million SEK | -2.37% |
| 2011 Q1 | 6.44 Million SEK | -5.69% |
| 2010 Q4 | 6.83 Million SEK | -8.38% |
| 2010 Q3 | 7.46 Million SEK | -5.74% |
| 2010 Q2 | 7.91 Million SEK | 1.36% |
| 2010 FY | 6.83 Million SEK | 647.21% |
| 2010 Q1 | 7.81 Million SEK | 753.55% |
| 2009 Q4 | 915 Thousand SEK | 0.0% |
| 2009 FY | 915 Thousand SEK | -98.05% |
| 2008 FY | 46.89 Million SEK | -34.77% |
| 2007 FY | 71.89 Million SEK | -12.0% |
| 2006 FY | 81.69 Million SEK | 47.38% |
| 2005 FY | 55.42 Million SEK | 2.31% |
| 2004 FY | 54.17 Million SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 97.164% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | -757.927% |
| Doxa AB (publ) | 9.7 Million SEK | -1446.392% |
| Elekta AB (publ) | 7.24 Billion SEK | 97.93% |
| iZafe Group AB (publ) | 3.17 Million SEK | -4624.409% |
| Ortivus AB (publ) | 5.48 Million SEK | -2636.727% |
| Ortivus AB (publ) | 5.48 Million SEK | -2636.727% |
| Q-linea AB (publ) | 20.56 Million SEK | -629.395% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 3.25 Billion SEK | 95.392% |